SIGN UP

top stories

Updated: Federal government defends lab-developed test rule in Texas court

10 hours ago

Nvidia and the Arc Institute just dropped a really, really big AI bio model

15 hours ago

RFK Jr. readies review of childhood vaccine schedule after pledging not to

17 hours ago

Hims buys at-home testing company Trybe Labs

10 hours ago

Latest

Ascletis’ obesity pill looks similar to Roche’s drug, early data suggest

15 hours ago

Another Chinese biotech files to go public in Hong Kong; A new ROR1 ADC deal

16 hours ago

Pfizer CEO says opportunities with Trump ‘clearly outweigh’ the risks for pharma

16 hours ago

Will CRISPR matter?

16 hours ago

Bare footprints and blocked inspectors: FDA places two Indian manufacturers on import alerts

16 hours ago

Startup that mines ‘junk DNA’ secures R&D deal with Merck

19 hours ago

see latest stream

People

Exclusive: Atomwise, a once high-flying AI startup, taps biotech vet as CEO to lead pared-down company

Yesterday

ARPA-H chief is out as Trump administration cuts health agencies

5 days ago

Kojin Therapeutics shuts down, citing lack of investor interest and complex science

5 days ago

Financing

Exclusive: Lux leads $25M Series A in a Lithuanian startup plotting US expansion

Yesterday

Pain biotech Latigo eyes up to $150M raise following Vertex's landmark FDA nod

Yesterday

BioNTech vets raise $90M Series A for bispecific I&I startup

5 days ago

Startups

Exclusive: CRISPR delivery startup, based on UC Berkeley and UCSF science, shuts down

22 hours ago

Hunger-suppressing biotech Aardvark raises $94M in IPO

6 days ago

Newleos, a new biotech with $93.5M, repurposes Roche's experimental CNS drugs

Last week

Deals

Arcus touts early kidney cancer data as Gilead declines option

Yesterday

After research pivot, Biogen beefs up pipeline with Stoke's late-stage Dravet candidate

Yesterday

How Bain’s $3.3B deal for centuries-old Tanabe Pharma came to fruition

5 days ago

In FocusSee all

Drugmakers seize on biomarkers to test the FDA's rare disease shift

3 weeks ago

Trump blog: States, universities beef up their argument against NIH's payment cuts

4 weeks ago

China's biotech boom is threatening US drugmakers' dominance

5 weeks ago

Broad Institute paper offers potential new framework for treating Huntington’s disease

Last month

Endpoints Standouts

How the world's biggest pharma and biotech companies paid their typical worker in 2023

7 months ago

In biotech's uneven recovery, 50 startups raised megarounds in first half of 2024

7 months ago

Biopharma leaders charting a path for the industry's LGBTQ+ community

7 months ago

Peter Marks single-handedly approved Sarepta’s gene therapy — what does that mean for everyone else?

8 months ago

Peer review See all

Feb

14

David Schenkein resigns from Agios’ board; Moderna hires Roivant exec as chief marketing officer

Feb

7

Longtime Sandoz exec announces retirement; Lilly appoints head of India

Jan

31

Roche separates CFO, informatics posts; Lilly execs land at Kailera, Neurocrine

Jan

24

Moderna information chief to retire next month; Pharming looks to Flagship for first new CEO since 2008

Jan

17

Kathy High leads GV, ARCH-backed eye disease biotech; Arvinas commercial exec steps down

Pharma channel feed

20 hours ago

Pfizer’s manufacturing arm at risk from Trump tariffs in Europe, Bourla says

Pfizer CEO Albert Bourla said its manufacturing business could be vulnerable to President Donald Trump’s tariffs in Europe as the pharma giant has "significant" presence in the region. ...

READ MORE

Former FDA chief calls job cuts ‘haphazard, poorly thought-out’

Yesterday

NIH payment cuts are 'reasoned and rational,' government says

Yesterday

latest in Pharma

Novo looks to recoup $830M from hypertension drug partner, claiming fraud

Yesterday

Siegfried’s stock slips over dampened sales outlook for 2025

Yesterday

Hikma takes Amarin's 'skinny label' fight to the Supreme Court

Yesterday

Bavarian Nordic wins FDA OK for chikungunya vaccine in challenge to Valneva

Yesterday

FDA approves Ono’s rare joint tumor drug, setting up battle with Daiichi

Yesterday

see latest stories

Marketing channel feed

Last month

J&J's new cancer combo beats AstraZeneca's Tagrisso on survival in lung trial

Johnson & Johnson said its recently approved Rybrevant and Lazcluze combination therapy topped Tagrisso on overall survival in a Phase 3 trial, notching a key win in its rivalry against ...

READ MORE

Drugs are approved — and made available — faster in US than most of EU, data show

2 months ago

Novartis bolsters Fabhalta data in competition with AstraZeneca

2 months ago

latest in Marketing

RFK Jr. and Elon Musk want to ban pharma ads. They wouldn't be the first to try

3 months ago

FDA says Merz's social media promotion with Nate Berkus is 'misleading'

3 months ago

Valneva and Pfizer eye 2027 launch for partnered Lyme disease vaccine

4 months ago

UK watchdog criticizes Moderna for Covid-19 trial's use of WhatsApp to dangle payments to children

4 months ago

FDA criticizes AbbVie's 'misleading' ad with Serena Williams

5 months ago

see latest stories

FDA+ channel feed

5 days ago

GSK follows Pfizer in meningococcal vaccine race with new FDA nod

GSK has snagged FDA approval for its 5-in-1 meningococcal vaccine, propelling it to a familiar position: rivaling Pfizer.

READ MORE

Healthcare shakeup hits Washington, with cuts at CDC, NIH and other agencies

5 days ago

Exclusive: Drugmakers plan Trump meeting next week amid Washington health shakeups

5 days ago

latest in FDA+

NIH’s funding cut plan poses challenges for researchers despite court halt

Last week

Kaiser Permanente calls on FDA and Congress to firm up accelerated approval requirements

Last week

Pfizer wins approval in new indication for blood cancer drug Adcetris

Last week

SpringWorks lands FDA approval for nerve tumor treatment

Last week

Travere plans to seek expanded label for kidney drug despite failed trial

Last week

see latest stories

Manufacturing channel feed

5 days ago

West Pharma loses two glucose device clients but is buoyed by its GLP-1 packaging services

West Pharmaceuticals Services’ stock $WST tanked by as much as 38% late Thursday after the packaging and delivery system provider said it was ending major contracts with two unnamed ...

READ MORE

Updated: Moderna reports $238M manufacturing write-down as cuts, new vaccines shape 2025

5 days ago

Syngene CEO departs; Lilly and AdvanCell sign radiotherapy partnership

6 days ago

latest in Manufacturing

FDA puts two Chinese API makers on import alert after failed inspections

Last week

Trump’s tariff impact likely ‘minimal’ for brand-name drugmakers, manufacturing partners

Last week

Belgian regulator recommends blocking Indian drugmaker's API production

Last week

AstraZeneca cuts UK funding pledge; Viking says it has ‘enough’ API for trials

Last week

Updated: Novo Nordisk sees growth slowing this year, plans CagriSema filing for 2026

2 weeks ago

see latest stories